Financial Performance - The company's operating revenue for Q3 2023 was ¥8,225,433,605.49, representing a decrease of 8.28% compared to the same period last year[4]. - Net profit attributable to shareholders for Q3 2023 was ¥186,852,024.02, an increase of 22.65% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥238,222,209.75, up 58.85% from the previous year[4]. - Basic earnings per share for Q3 2023 was ¥0.0725, reflecting a growth of 22.88% year-on-year[4]. - The net profit for Q3 2023 was CNY 1,489,456,704.40, a decrease from CNY 1,558,784,901.19 in Q3 2022, representing a decline of approximately 4.4%[17]. - The total profit for Q3 2023 was CNY 1,909,710,596.36, compared to CNY 1,858,685,920.06 in Q3 2022, indicating a growth of about 2.8%[17]. - The operating profit for Q3 2023 was CNY 1,912,579,458.96, slightly higher than CNY 1,875,209,265.23 in Q3 2022, showing an increase of approximately 2.4%[17]. - The total comprehensive income for Q3 2023 was CNY 1,496,651,119.16, down from CNY 1,585,282,325.66 in Q3 2022, representing a decrease of approximately 5.6%[18]. Cash Flow - The net cash flow from operating activities for the year-to-date period reached ¥3,924,570,676.43, a significant increase of 1,820.89% compared to the same period last year[4]. - The net cash flow from operating activities for Q3 2023 was ¥3,924,570,676.43, a significant improvement from a net outflow of ¥228,054,074.04 in Q3 2022[20]. - Total cash inflow from investment activities was ¥2,790,656,816.54, compared to ¥2,702,799,717.04 in the same period last year[20]. - The net cash flow from investment activities showed a loss of ¥1,949,288,105.46, an improvement from a loss of ¥3,649,689,361.48 in Q3 2022[20]. - Cash inflow from financing activities totaled ¥6,086,231,876.96, down from ¥12,409,939,796.56 in Q3 2022[20]. - The net cash flow from financing activities was negative at -¥1,976,766,556.51, compared to a positive flow of ¥4,166,008,995.66 in the previous year[20]. - The total cash and cash equivalents at the end of Q3 2023 amounted to ¥7,881,683,236.20, an increase from ¥6,377,775,854.83 at the end of Q3 2022[20]. Assets and Liabilities - Total assets at the end of the reporting period were ¥52,293,310,406.08, a decrease of 4.02% from the previous year-end[4]. - The total assets decreased to ¥50,278,681,050.20 from ¥52,385,798,596.69, a reduction of 4%[15]. - The total liabilities decreased to ¥29,962,565,922.47 from ¥33,542,017,842.73, a decline of 10.5%[15]. - The company reported a total asset value of ¥52,385,798,596.69 as of January 1, 2023, reflecting an increase from ¥52,293,310,406.08 at the end of 2022[23]. - The total liabilities rose from ¥33,450,764,548.03 at the end of 2022 to ¥33,542,017,842.73 as of January 1, 2023[23]. Equity - The equity attributable to shareholders at the end of the reporting period was ¥9,133,813,548.67, an increase of 7.76% compared to the previous year-end[4]. - The company’s total equity increased to ¥20,316,115,127.73 from ¥18,843,780,753.96, reflecting a growth of 7.8%[15]. - The company’s total equity attributable to shareholders increased slightly from ¥9,133,813,548.67 at the end of 2022 to ¥9,135,864,452.50 as of January 1, 2023[23]. Investment and Financing - The company increased its long-term borrowings by 82.45%, reaching ¥8,995,465,306.31 due to new long-term loans[7]. - The company reported a significant increase in long-term borrowings, which rose to ¥8,995,465,306.31 from ¥4,930,271,374.05, an increase of 82%[15]. - Interest income decreased by 69.90% to ¥8,301,218.20 compared to ¥27,574,921.59 in the same period last year due to the contraction of microloan business[8]. - Investment income fell by 59.00% to ¥175,858,733.30 from ¥428,963,478.75, primarily due to high investment returns from joint ventures in the previous year[8]. Impairment Losses - The company’s subsidiaries reported a significant reduction in credit impairment losses by 76.63% to -¥27,349,016.51, compared to -¥117,032,081.55 in the previous year[8]. - The company’s subsidiaries reported an increase in asset impairment losses by 228.15% to -¥69,447,034.73, attributed to increased inventory write-downs due to market conditions[8]. Other Agreements and Projects - The company completed the transfer of 59.469 million shares of Shenzhen Dafu Pharmaceutical Co., Ltd. at ¥4.38 per share to Hangzhou Yunbai Pharmaceutical Technology Co., Ltd.[11]. - The company signed a supplementary agreement for the urban renewal project in Longgang District, Shenzhen, focusing on "urban renewal + benefit coordination"[11]. - A joint venture agreement was amended to adjust the construction site for a new energy lithium battery anode material project in Indonesia[11].

中国宝安集团股份有限公司董事局 关于下属子公司申请公开发行股票并在北交所上市 辅导备案的提示性公告 本公司及董事局全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 中国宝安集团股份有限公司（以下简称"公司"）控股子公司张家港友诚新能 源科技股份有限公司（以下简称"友诚科技"）为全国中小企业股份转让系统挂牌 企业，证券简称：友诚科技，证券代码：873087。友诚科技于 2023 年 9 月 20 日 向中国证券监督管理委员会江苏监管局提交了向不特定合格投资者公开发行股 票并在北京证券交易所上市的辅导备案材料，辅导机构为东吴证券股份有限公司。 具体内容请详见友诚科技 2023 年 9 月 22 日在全国股转公司官网披露的《申请公 开发行股票并在北交所上市辅导备案公告》（公告编号：2023-049）。敬请广大投 资者注意投资风险。 特此公告 证券代码：000009 证券简称：中国宝安 公告编号：2023-035 中国宝安集团股份有限公司 二〇二三年九月二十三日 1 ...

证券代码：000009 证券简称：中国宝安 公告编号：2023-034 中国宝安集团股份有限公司 关于马应龙股份解除质押及再质押的公告 本公司及董事局全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 中国宝安集团股份有限公司（以下简称"中国宝安"或"本公司"）于 2023 年 9 月 19 日在中国证券登记结算有限责任公司与中国银行股份有限公司深圳罗 湖支行办理了本公司持有的马应龙药业集团股份有限公司（以下简称"马应龙"） 10,000,000 股无限售流通股解除质押手续，并在同日将 10,000,000 股无限售流通 股再次质押给中国银行股份有限公司深圳罗湖支行，具体事项如下： | 股东 | 是否为控股股东 | 本次解除质押 | 占本公司所 | 占马应 | | | 解除 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 或第一大股东及 | 股份数量 | 持股份比例 | 龙总股 | 起始日 | | 日期 | | 质权人 | | | 其一致行动人 | （股） | | 本比例 | ...

中国宝安集团股份有限公司董事会： 2019年 6月27日，你公司股东大会完成了第十四届董事局、 第十届监事会的换届选举。根据你公司《公司章程》，董事、监 事的任期均为三年，你公司第十四届董事局、第十届监事会的任 期现均已届满。截至目前，你公司仍未完成董事局和监事会的换 届选举工作，也未披露董事局和监事会延期换届事项具体进展。 我部对上述事项表示关注。请你公司尽快完成董事局和监事 会的改选工作，及时披露相关工作进展，确保生产经营、信息披 露等工作的稳定性。同时，提醒你公司及全体董事、监事和高级 管理人员严格遵守《证券法》《公司法》等法律法规，以及本所 《股票上市规则》等规定，真实、准确、完整、及时、公平地履 行信息披露义务。 深 圳 证 券 交 易 所 关于对中国宝安集团股份有限公司的关注函 公司部关注函〔2023〕第 305 号 1 深圳证券交易所 上市公司管理二部 2023 年 9 月 7 日 2 特此函告 ...

Financial Performance - The company's operating revenue for the first half of 2023 was CNY 16,282,917,663.35, representing a 20.51% increase compared to CNY 13,511,408,089.55 in the same period last year[12]. - Net profit attributable to shareholders of the listed company was CNY 491,669,061.64, up 16.18% from CNY 423,195,842.67 in the previous year[12]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 23.22% to CNY 329,671,097.09 from CNY 429,373,017.46[12]. - Basic earnings per share increased to CNY 0.1906, reflecting a 16.15% rise from CNY 0.1641[12]. - The company achieved total operating revenue of 1,629,019.86 million CNY in the first half of 2023, a year-on-year increase of 20.39%[22]. - The company's net profit attributable to shareholders reached 49,166.91 million CNY, reflecting a growth of 16.18% compared to the same period last year[22]. Cash Flow and Financial Position - The net cash flow from operating activities was CNY 3,077,547,200.25, a significant increase of 1,511.35% compared to a negative cash flow of CNY 218,056,954.00 in the previous year[12]. - The company reported a significant decrease in short-term loans by 56.68% to ¥3,602,196,975.75, attributed to the repayment of maturing loans[32]. - Cash and cash equivalents at the end of the reporting period amounted to ¥8,473,488,440.74, representing 17.19% of total assets, a decrease of 2.91% from the previous year[37]. - The company's total liabilities reached RMB 29.49 billion, down from RMB 33.54 billion, indicating a reduction of about 12.1%[120]. - The company's equity attributable to shareholders increased to RMB 9.65 billion from RMB 9.14 billion, reflecting a growth of about 5.6%[120]. Investment and Subsidiaries - The company has established a comprehensive capital operation capability, integrating industrial and capital operations to support its expansion strategy[21]. - The subsidiary BetterRay reported sales revenue of 1,342,273.66 million CNY, a 31.59% increase, but net profit decreased by 7.69% to 84,728.08 million CNY due to high inventory clearance and price declines[24]. - The company has set up several new subsidiaries, including Indonesia Betterray New Energy Materials Co., Ltd., with no significant impact on overall operations[52]. Industry Focus and Strategy - The high-tech industry is a key focus for the company, aligning with national strategies to develop new energy materials and the new energy vehicle industry, which are expected to grow significantly[16]. - The company is committed to continuous technological innovation and upgrading its business model in the biopharmaceutical sector to enhance resource value[17]. - The company plans to enhance operational efficiency in real estate by focusing on inventory reduction and sales promotion strategies[18]. Environmental Compliance and Initiatives - The company is committed to adhering to various environmental protection laws and standards in its operations[61]. - The company has obtained pollution discharge permits for several subsidiaries, with validity extending to 2027 and beyond[62]. - The company achieved a sulfur dioxide emission of 71.06 tons per year, indicating a focus on reducing environmental impact[64]. - The company has established multiple industrial waste gas discharge outlets, with a total of 13 identified[64]. - Betterray New Materials Group invested approximately 51.58 million yuan in environmental monitoring, hazardous waste treatment, and maintenance of environmental protection facilities in the first half of 2023[73]. Legal Matters and Disputes - The company is involved in a lawsuit regarding a land lease agreement, with a claimed amount of RMB 7,999,200 and interest of RMB 16,353,100[85]. - The company has filed a lawsuit against Henan Guoneng Battery Co., Ltd. and Beijing Guoneng Battery Technology Co., Ltd. for overdue payments and interest amounting to CNY 201.80 million[86]. - The company is actively involved in the bankruptcy proceedings of Zhuzhou Watma Battery Co., Ltd., with ongoing claims for overdue payments[86]. Risk Management - The company has disclosed risk factors and corresponding measures in the management discussion and analysis section of the report[2]. - The company faces risks related to industry policies, technology replacement, and supply chain dynamics in its high-tech and biopharmaceutical sectors[53][54]. - The company is focusing on risk control and management improvement in the real estate sector, aiming to enhance sales capabilities and accelerate inventory turnover[56]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 202,752, with 10 shareholders holding more than 5% of the shares[103]. - The largest shareholder, Shenzhen Chengxing Investment Co., Ltd., holds 426,868,042 shares, accounting for 16.55% of the total shares[105]. - The company reported a total of CNY 2,516.26 million in actual guarantees during the reporting period[95].

上市公司2023年半年度非经营性资金占用及其他关联资金往来情况汇总表 编制单位：中国宝安集团股份有限公司 | 非经营性资金占 | | 占用方与上市公 | 上市公司核算 | 2023年初占用资金 | 2023年1-6月占用累 | 2023年1-6月占用资 | 2023年1-6月偿还累 | 2023年6月末占用资 | | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 用 | 资金占用方名称 | 司的关联关系 | 的会计科目 | 余额 | 计发生金额（不含 利息） | 金的利息（如有） | 计发生额 | 金余额 | 占用形成原因 | | | 现大股东及其附 | | | | | | | | | | | | 属企业 | | | | | | | | | | | | 小 计 | —— | —— | —— | | - | - | - | | —— | —— | | 前大股东及其附 | | | | | | | | | | | | 属企业 | | | | | | | | | | | | 小 计 | —— | —— | —— ...

二〇二三年八月二十八日 （1）未发现公司存在大股东及其关联方资金占用的现象。 （2）公司十分重视对外担保的控制，对符合规定的担保有专门的审批流程， 并有专人对担保事项进行实时跟踪。报告期内，公司对外担保按相关规定履行了 决策程序和信息披露义务，不存在违规对外担保的情况。截止 2023 年 6 月 30 日， 公司对外担保均处于受控状态，无逾期担保和涉及诉讼的担保，公司对外担保没 有损害公司及公司股东尤其是中小股东的合法权益。 独立董事：梁发贤、李瑶、徐志鸿 中国宝安集团股份有限公司独立董事 对关联方资金占用及对外担保情况的专项说明和独立意见 根据《上市公司治理准则》、《公司章程》及其他有关规定对公司 2023 年上 半年关联方资金占用及对外担保等事项进行了认真审核。 ...

证券代码：000009 证券简称：中国宝安 公告编号：2023-032 中国宝安集团股份有限公司 关于股东减持计划届满暨实施情况的公告 股东深圳市富安控股有限公司保证向本公司提供的信息内容真实、准确、完整，没有虚 假记载、误导性陈述或者重大遗漏。 本公司及董事局全体成员保证公告内容与信息披露义务人提供的信息一致。 减持股份来源：首次公开发行股票前获得的股份。 二、其他相关说明 1、本次减持计划符合《证券法》《上市公司股东、董监高减持股份的若干指 引》《深圳证券交易所上市公司股东及董事、监事、高级管理人员减持股份实施 细则》等相关法律、法规及规范性文件的规定。 2、截至 2023 年 8 月 16 日，富安公司减持计划时间区间届满，本次减持实 施情况与此前预披露的减持意向、承诺、减持计划一致。 三、备查文件 中国宝安集团股份有限公司（以下简称"本公司"或"中国宝安"）于 2023 年 8 月 16 日收到股东深圳市富安控股有限公司（以下简称"富安公司"）出具的 《关于股份减持计划届满暨实施情况的告知函》，富安公司委托本公司于 2023 年 4 月 19 日在巨潮资讯网披露了《关于持股 5%以上股东减持计划的预披 ...

中国宝安集团股份有限公司（以下简称"公司"或"中国宝安"）于 2021 年 8 月 18 日发行的中国宝安集团股份有限公司 2021 年面向合格投资者公开发行公 司债券（第一期）（以下简称"21 宝安 01"、"本期债券"、债券代码：149600） 至 2023 年 8 月 18 日将期满 2 年。根据公司本期债券《2021 年面向合格投资者 公开发行公司债券（第一期）募集说明书》及《2021 年面向合格投资者公开发行 公司债券（第一期）上市公告书》有关条款的规定，在本期债券的计息期限内， 每年付息一次，现将有关事宜公告如下： 一、本期债券基本情况 1、债券名称：中国宝安集团股份有限公司 2021 年面向合格投资者公开发行 公司债券（第一期）（本期债券简称为"21 宝安 01"，债券代码为"149600"） | 债券代码：149600 | 债券简称：21 | 宝安 | | --- | --- | --- | | 债券代码：148037 | 债券简称：22 宝安 | | | | 01 01 | | | | | 公告编号：2023-030 | | 证券代码：000009 | 证券简称：中国宝安 | | 中国宝安集 ...

二、股东累计质押股份情况 截至 2023 年 8 月 8 日，韶关高创累计质押股份情况如下： 证券代码：000009 证券简称：中国宝安 公告编号：2023-029 中国宝安集团股份有限公司 关于大股东股权质押的公告 本公司及董事局全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或者重大遗漏。 本公司于 2023 年 8 月 8 日收到大股东韶关市高创企业管理有限公司（下称 "韶关高创"）的通知，获悉韶关高创于 2023 年 8 月 7 日将其所持有本公司的 90,000,000 股股份质押给中信证券股份有限公司，具体事项如下： | 股东 | 是否为控股 股东或第一 | 本次质押 | 占其所 | 占公司 | 是否 | 是否为 | 质押 | | 质押 | | | 质押 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 大股东及其 | 数量（股） | 持股份 | 总股本 | 为限 | 补充质押 | 起始日 | | 到期日 | | 质权人 | 用途 | | | 一致行 ...